Shanghai’s Brii Bioscience Invests in Artizan; Gains China Rights to Microbiota Treatment for IBD Jun 11, 2019 Life Science
Everest Medicines Acquires China Rights to Kidney Disease Treatment in $121 Million Pact Jun 10, 2019 Life Science
CStone received approval to initiate clinical development in China of CS1001 and BLU-554 (CS3008) in combination therapy for HCC Jun 5, 2019 Life Science
Frontage Holdings Corporation Celebrates a Successful Initial Public Offering on the HKEx Jun 4, 2019 Life Science
Jiangsu Provincial Institute of Materia Medica Selects Provantis Preclinical SaaS Solution Jun 4, 2019 Life Science
Medical Marijuana, Inc. Announces International Coverage at FDA Public Hearing on Cannabis and CBD Products Jun 3, 2019 Cannabis, Life Science
